Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

REDAPT Modular Acetabular Shell

K-Number: K182109 · 2018-11-16

Decision Date2018-11-16
Product CodeLPH
Advisory CommitteeOR
DecisionSubstantially Equivalent

Device Summary

REDAPT Modular Acetabular Shell is a medical device manufactured by Smith & Nephew, Inc.. It received FDA 510(k) clearance on 2018-11-16 under approval number K182109. The device is classified under product code LPH. It was reviewed by the OR advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the REDAPT Modular Acetabular Shell?

REDAPT Modular Acetabular Shell is a medical device that received FDA 510(k) clearance on 2018-11-16. It is manufactured by Smith & Nephew, Inc.. The 510(k) number is K182109.

When was REDAPT Modular Acetabular Shell approved by the FDA?

REDAPT Modular Acetabular Shell received FDA 510(k) clearance on 2018-11-16, under approval number K182109.

What company makes REDAPT Modular Acetabular Shell?

REDAPT Modular Acetabular Shell is manufactured by Smith & Nephew, Inc..

What is the FDA product code for REDAPT Modular Acetabular Shell?

The FDA product code for REDAPT Modular Acetabular Shell is LPH.

Related Clinical Trials

Other Devices by Smith & Nephew, Inc.

View all 107 devices →

Related Devices (Code: LPH)

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.